Comparing the risk of tardive dyskinesia in older adults with first-generation and second-generation antipsychotics: a systematic review and meta-analysis

International Journal of Geriatric Psychiatry

Volumn 31, Issue 7, 2016, Pages 683-693

  O’Brien, Angela ^a  

^a WAITEMATA DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

antipsychotics; older; tardive dyskinesia

Indexed keywords

NEUROLEPTIC AGENT;

DRUG USE; HIGH RISK POPULATION; HUMAN; INCIDENCE; META ANALYSIS; PREVALENCE; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TARDIVE DYSKINESIA; AGED; CHEMICALLY INDUCED; MIDDLE AGED; RISK;

AGED; ANTIPSYCHOTIC AGENTS; HUMANS; INCIDENCE; MIDDLE AGED; PREVALENCE; RISK; TARDIVE DYSKINESIA;

EID: 84952064530     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.4399     Document Type: Review

References (44)

1. Blumberger DM, Mulsant BH, Kanellopoulos D, et al. 2013. The incidence of tardive dyskinesia in the study of pharmacotherapy for psychotic depression. J Clin Psychopharmacol 33: 391–397.
2. Byne W, White L, Parella M, et al. 1998. Tardive dyskinesia in a chronically institutionalized population of elderly schizophrenic patients: prevalence and association with cognitive impairment. Int J Geriatr Psychiatry 13: 473–479.
3. Chacko RC, Roor R, Marmion J, Molinari V, Adams GL. 1985. The prevalence of tardive dyskinesia in geropsychiatric outpatients. J Clin Psychiatry 46: 55–57.
4. Chiu HFK, Wing YK, Kwong PK, Leung CM, Lam LCW. 1993. Prevalence of tardive dyskinesia in samples of elderly people in Hong Kong. Acta Psych Scand 87: 266–268.
5. Chouinard G, Ross-Chouinard A, Annable L, Jones BD. 1980. Extrapyramidal symptom rating scale. Can J Neurol Sci 7: 233.
6. Correll CU, Leucht S, Kane JM. 2004. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry 161: 414–425.
7. Correll CU, Schenk EM. 2008. Tardive dyskinesia and new antipsychotics. Curr Opin Psychiatry 21: 151–156.
8. Davidson M, Harvey PD, Vervarcke CA, et al. 2000. A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. Int J Geriatr Psychiatry 15: 506–514.
9. DerSimonian R, Laird N. 1986. Meta-analysis in clinical trials. Control Clin Trials 7: 177–188.
10. Dolder CR, Jeste DV. 2003. Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients. Biol Psychiatry 53: 1142–1145.
11. Egan MF, Apud J, Wyatt RJ. 1997. Treatment of tardive dyskinesia. Schiz Bull 23: 583–609.
12. Guy, W. 1976. ECDEU assessment manual for psychopharmacology, revised. Rockville, MD. National Institute of Mental Health, DHEW Publication No. (ADM) 76-338, 534–7.
13. Harris MJ, Panton D, Caligiuri MP, et al. 1992. High incidence of tardive dyskinesia in older outpatients on low doses of neuroleptics. Psychopharmacol Bull 28: 87–92.
14. Hunter CB, Kenney C, Meija N, Davidson A, Jankovic J. 2006. Medications associated with the onset of tardive dyskinesia. Neurology. https://www.bcm.edu/neurology/pdf/poster_pdcmdc_Meds_TDysk_ANA.pdf
15. Jeste DV, Caliguri MP, Paulsen JS, et al. 1995. Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients. Arch Gen Psychiatry 52: 756–765.
16. Jeste DV, Lacro JP, Palmer B, et al. 1999a. Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients. Am J Psychiatry 156: 309–311.
17. Jeste DV, Rockwell E, Harris MJ, Lohr JB, Lacro J. 1999b. Conventional vs newer antipsychotics in elderly patients. Am J Geriatr Psychiatry 7: 70–76.
18. Jeste DV, Lacro JP, Bailey A, et al. 1999c. Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J Am Geriatr Soc 47: 716–9.
19. Jeste DV, Okamoto A, Napolitano J, Kane JM, Martinez RA. 2000a. Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone. Am J Psychiatry 157: 1150–1155.
20. Jeste DV, Glazer W, Morgenstern H, Pultz JA, Yeung P. 2000b. Low incidence of tardive dyskinesia with quetiapine treatment of psychotic disorders in the elderly [poster]. Presented at the 13th Annual Meeting of the American Association for Geriatric Psychiatry; March 12–15, Miami, Florida.
21. Kazamatsuri H, Chien C-P, Cole JO. 1972. Therapeutic approaches to tardive dyskinesia. Arch Gen Psychiatry 27: 491–499.
22. Kinon BJ, Kollack-Walker S, Jeste D, et al. 2015. Incidence of tardive dyskinesia in older patients treated with olanzapine or conventional antipsychotics. J Geriatr Psychiatry Neurol 28: 67–79.
23. Miller DD, Caroff SN, Davis SM, et al. 2008. Extrapyramidal side-effects of antipsychotics in a randomized trial. Br J Psychiatry 193: 279–288.
24. Moher D, Liberati A, Tezlaff J, Altman DG, Group P. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Int Med 151: 264–269.
25. OpenMetaAnalyst, Wallace BC, Dahabreh IJ, et al. 2012. Closing the gap between methodologists and end-users: R as a computational back-end. J Stat Softw 49: 5.
26. Peluso MJ, Lewis SW, Barnes TRE. 2012. Extrapyramidal motor side effects of first- and second-generation antipsychotic drugs. Br J Psychiatry 200: 387–392.
27. Saltz BL, Woerner MG, Kane JM, et al. 1991. Prospective study of tardive dyskinesia incidence in the elderly. JAMA 266: 2402–2406.
28. Schonecker M. 1957. Ein eigentumliches Syndrom im oralen Bereich bei Megaphenapplikation. Nervenarzt 28: 35.
29. Schooler NR, Kane JM. 1982. Research diagnoses for tardive dyskinesia. Arch Gen Psychiatr 39: 486–487.
30. Simpson GM, Lee JH, Zoubok B, Gardos G. 1979. A rating scale for tardive dyskinesia. Psychopharmacology (Berl) 64: 171–179.
31. Smith JM, Oswald WT, Kucharksi LT, Watermen LT. 1978. Tardive dyskinesia: age and sex differences in hospitalized schizophrenics. Psychopharmacology (Berl) 58: 207–211.
32. Smith JM, Kucharski LT, Eblen C, Knutsen E, Linn C. 1979. An assessment of tardive dyskinesia in schizophrenic outpatients. Psychopharmacology (Berl) 64: 99–104.
33. Stroup DF, Berlin JA, Morton SC, et al. 2000. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008–2012.
34. Sweet RA, Mulsant B, Gupta B, et al. 1995. Duration of neuroleptic treatment and prevalence of tardive dyskinesia in late life. Arch Gen Psychiatry 52: 478–486.
35. Tenback DE, van Harten PN, Slooff CJ, et al. 2005. Effects of antipsychotic treatment on tardive dyskinesia: a 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) Study. J Clin Psychiatry 66: 1130–1133.
36. Toenniessen LM, Casey DE, Bentson H, McFarland BH. 1985. Tardive dyskinesia in the aged: duration of treatment relationships. Arch Gen Psychiatry 42: 278–284.
37. Waddington JL, Youssef HA. 1988. Tardive dyskinesia in bipolar affective disorder: aging, cognitive dysfunction, course of illness, and exposure to neuroleptics and lithium. Am J Psychiatry 145: 613–616.
38. Waln O & Jankovic J. 2013. An update on tardive dyskinesia: from phenomenology to treatment. Tremor and Other Hyperkinetic Movements 3: http://tremorjournal.org/article/view/161.
39. Weiden PJ, Mann JJ, Mattson M, Frances A. 1987. Clinician nonrecognition of neuroleptic-induced movement disorders: a cautionary study. Am J Psychiatr 144: 1148–1153.
40. Woerner MG, Alvir JMJ, Saltz BL, Lieberman JA, Kane JM. 1998. Prospective study of tardive dyskinesia in the elderly: rates and risk factors. Am J Psychiatry 155: 1521–1528.
41. Woerner MG, Correll CU, Alvir JM, et al. 2011. Incidence of tardive dyskinesia with risperidone or olanzapine in the elderly: results from a 2-year, prospective study in antipsychotic-naïve patients. Neuropsychopharmacology 36: 1738–1746.
42. Woods SW. 2003. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 64: 663–667.
43. Yassa R, Nastase C, Dupont D, Thibeau M. 1992. Tardive dyskinesia in elderly psychiatric patients: a 5 year study. Am J Psychiatry 149: 1206–1211.
44. Yassa R, Jeste DV. 1992. Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr Bull 18: 701–715.